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Abstract: DNA damage quantitation assays such as the comet assay have focused on the measurement
of total nuclear damage per cell. The adoption of PCR-based techniques to quantify DNA damage
has enabled sequence- and organelle-specific assessment of DNA lesions. Here we report on an
adaptation of a qPCR technique to assess DNA damage in nuclear and mitochondrial targets relative
to control. Novel aspects of this assay include application of the assay to the Rotor-Gene platform
with optimized DNA polymerase/fluorophore/primer set combination in a touchdown PCR protocol.
Assay validation was performed using ultraviolet C radiation in A549 and THP1 cancer cell lines.
A comparison was made to the comet assay applied to peripheral blood mononuclear cells, and an
estimation of the effects of cryopreservation on ultraviolet C-induced DNA damage was carried
out. Finally, dose responses for DNA damage were measured in peripheral blood mononuclear
cells following exposure to the cytotoxic agents bleomycin and cisplatin. We show reproducible
experimental outputs across the tested conditions and concordance with published findings with
respect to mitochondrial and nuclear genotoxic susceptibilities. The application of this DNA damage
assay to a wide range of clinical and laboratory-derived samples is both feasible and resource-efficient.
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1. Introduction
The integrity of genomic and mitochondrial DNA is under constant threat from endogenous
reactive oxygen species produced by normal cellular metabolism and exogenous sources such as
ultraviolet light and mutagens. To counter this, organisms use a complex network of pathways/
processes that sense and repair defects, collectively referred to as the DNA damage response (DDR) [1].
However, loss of function mutations or epigenetic silencing of DDR genes—which are associated with
human malignancies and inherited disorders such as Fanconi anaemia and Bloom’s syndrome—can
prevent repair of DNA [2]. A reliable method that detects and quantifies DNA lesions is valuable in
understanding disease-specific pathologies and screening chemical and environmental contaminants
for genotoxic effects.
Quantification of mutagenic effects originated with the micronucleus assay [3], which was largely
superseded by the single-cell gel electrophoresis or comet assay [4]. This method quantifies the
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migration of damaged DNA fragments from the nucleoid under electrophoresis and has become the
gold standard for measuring cellular DNA damage. However, researchers are exploring PCR-based
approaches, where DNA damage results in the disruption of DNA polymerase activity and impaired
DNA synthesis. Early investigations used semi-quantitative PCR approaches with target amplicons of
between ~450 bp and 25 kb [5,6], which has been updated to incorporate quantitative PCR (qPCR) [7];
however, due to the multistep validation required, its use is not straightforward. Contemporaneously,
the long-run qPCR technique for DNA-damage quantification (LORD-Q) method was developed [8],
in which a high frequency of lesions in the DNA template corresponds to a lower concentration of
full-length template and therefore a higher threshold value of the amplified product relative to the
undamaged template. This technique utilized oligonucleotide primers designed for 3–4 kb target
fragments and small internal amplicons of ~100 bp, and was able to quantify DNA damage induced
by a range of genotoxic stimuli and interrogate specific DNA loci in both mitochondrial and genomic
DNA with reproducible sensitivity. However, this method has not been widely tested on different
instruments (the published report used Roche LightCycler 480 II instrument) and has the disadvantage
of requiring an expensive DNA polymerase and fluorophore.
Here we report a modified long-run qPCR assay for use on a Corbett Rotor-Gene 6000 instrument,
with alternative primer sets for both nuclear and mitochondrial DNA loci. The method allows both
small and large products to be amplified under the same PCR conditions using considerably cheaper
consumables than the published method. Our approach was validated by measuring DNA damage
in: (1) cryopreserved and freshly-isolated peripheral blood mononuclear cells (PMBCs) exposed to
ultraviolet C (UVC) radiation (254 nm); (2) suspension and adherent cancer cell lines exposed to UVC;
and (3) cryopreserved PBMCs damaged by cytotoxic chemotherapy (cisplatin and bleomycin).
2. Materials and Methods
2.1. Cell Culture
THP1 and A549 human cell lines were obtained from ATCC and cultured in RPMI-1640 +
GlutaMAX (Gibco, Grand Island, NY, USA), supplemented with 10% heat-inactivated fetal calf serum
(FCS, Gibco, USA), penicillin, and streptomycin (Gibco, USA). All cell culture experiments were carried
out in a humidified incubator at 5% CO2 and 37 ◦C. Adherent cells were harvested by trypsin incubation
using 0.05% trypsin in EDTA (Gibco, USA). PBMCs were extracted from buffy coats collected from
healthy blood donors by the NZ Blood Service under ethical approval from the Northern B Health
and Disability Ethics Committee (reference NTY/10/08/065/AM01). Buffy coats were diluted with
phosphate-buffered saline (PBS, pH 7.4) and layered over Histopaque 1077 (Sigma-Aldrich, St Louis,
MO, USA) in 15 mL conical sterile polypropylene centrifuge tubes (Greiner Bio-One, Frickenhausen,
Germany, The cells were centrifuged at 400 g for 30 min, the interphase removed and washed
three times in 10 mL of sterile PBS and centrifuged at 250 g to remove residual platelets. Finally,
the cells were quantified in a Neubauer chamber (Fortuna, Wertheim, Germany) and viability was
assessed by 0.4% w/v trypan blue exclusion (Sigma-Aldrich) in PBS. Samples were used in the
experiments if viability exceeded 85%.
2.2. Cryopreservation of PBMCs
PBMCs were resuspended in sterile filtered 50% FCS (Gibco, USA), 40% RPMI (Gibco, USA) and
10% DMSO (Merck, Darmstadt, Germany) in 1.8 mL Nunc™ conical sterile polypropylene cryo vials
(Thermo Scientific, Waltham, MA, USA) and placed overnight in a CoolCell® (Biocision, Larkspur,
CA, USA) at −80 ◦C for controlled cooling. These cells were then stored for 2, 4, 8, or 12 weeks
at −80 ◦C. When required, PBMC aliquots were thawed rapidly in a 37 ◦C water bath, gradually
equilibrated with pre-warmed culture media, diluted to 10× the original culture volume, and the cells
were pelleted by centrifugation in a refrigerated centrifuge (Eppendorf, Hamburg, Germany) at 300 g
for 10 min. The residual storage media was discarded to ensure no carryover of DMSO, and the cells
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were resuspended and maintained in RPMI-1640 + GlutaMAX (Gibco, USA) and supplemented with
10% heat-inactivated FCS (Gibco, USA) in standard culture conditions for 24 h before UVC irradiation
or treatment with cytotoxic compounds.
2.3. UVC Irradiation of Cells
UVC irradiation was carried out on THP1, A549, and fresh or cryopreserved PBMC cells. Cell
concentrations were 2.5–5× 105/mL for A549 cells, 5× 105/mL for THP1, and 1× 106/mL for PBMCs,
aliquoted into identical 2 mL media volumes in six-well Nunclon™ Delta plates (Thermo Scientific,
USA). UVC doses of either 20 or 100 millijoules per cm2 (mJ/cm2) were given to each plate using the
Bio-link BXL-254 cross-linker (Gibco, USA). Cells were harvested immediately after UVC exposure,
and were prepared for DNA extraction, except for aliquots of fresh PBMCs that were used within the
alkaline comet assay.
2.4. Cytotoxic Chemotherapy Incubation
Bleomycin and cisplatin concentrations were chosen to match those used in a previous study [8].
A 10 mg vial of bleomycin (Hospira, Lake Forest, IL, USA ) was reconstituted in sterile 0.9% w/v
sodium chloride and stocks frozen at −20 ◦C. Revived PBMCs were resuspended in serum-free media
RPMI-1640 (Gibco, USA) in six-well Nunclon™ Delta plates (Thermo Scientific, USA) containing
2.5 × 106 cells per well with bleomycin at concentrations of 10, 20, 30, or 40 µM or vehicle (0.9% w/v
sodium chloride). Plates were incubated for 30 min at 37 ◦C in 5% CO2, after which cells were washed
in PBS and prepared for DNA extraction. A 1 mg/mL stock solution of cisplatin (Novartis, Auckland,
New Zealand) was diluted to the required concentration in complete media RPMI-1640 (Gibco, USA).
Revived PBMCs were resuspended in complete media RPMI-1640 (Gibco, USA) in six-well Nunclon™
Delta plates (Thermo Scientific, USA) containing 2.5× 106 cells per well with cisplatin at concentrations
of 50 or 100 µM or media control. Plates were incubated for 24 h at 37 ◦C in 5% CO2, after which cells
were washed in PBS and prepared for DNA extraction.
2.5. DNA Extraction
Total cell DNA was isolated and purified using Quick-gDNATM Miniprep (Zymo Research, Irvine,
CA, USA) as per the manufacturer’s instructions from control and treated cells. The cells were washed
in PBS and then lysed immediately after UV or chemotherapy treatment by application of 400 µL of
the Quick-gDNATM Miniprep lysis reagent to adherent cells directly on the plate or to suspension
cells after 5 min centrifugation at 200 g. DNA eluted in TE buffer (10 mM Tris-HCl/1 mM EDTA) was
quantified, and an assessment of DNA purity was determined on a NanoDrop 2000 (Thermo Scientific,
USA) by spectrometric analysis. An aliquot of the high quality DNA (A260:280 > 1.8) was subsequently
stored at 4 ◦C.
2.6. Alkaline Comet Assay
Fronine microscope slides (Thermo Fisher, Taren Point, Australia) were cleaned, coated with
molten 1% HyAgarose™ LE Agarose (Hydragene, Xiamen, China) by emersion, and air-dried.
Experimentally-treated cells at a concentration of 1 × 104 cells per slide were mixed into 37 ◦C
0.5% low melting point (LMP) SeaPlaque™ GTG™ Agarose (FMC Bioproducts, Rockland, ME, USA)
in PBS and pipetted onto the agarose-coated slides. A 15 × 40 mm coverslip was immediately placed
on the LMP agarose/cell solution, and the slides were left to gel at 4 ◦C in the dark for 20 min. Next,
the slides were placed in comet lysis solution (pH 10; 2.5 M sodium chloride, 100 mM EDTA, 1.2 mM
Tris-HCl, and 0.1% SDS), with 0.015% Triton X-100 added immediately prior to use, for 2 h at 4 ◦C.
Slides were then washed in cold PBS for 5 min and then placed in an Owl™ D3 Electrophoresis
System chamber (Thermo Scientific, USA) containing approximately 650 mL of alkaline electrophoresis
buffer (pH > 13; 300 mmol sodium hydroxide, 1 mmol disodium EDTA) for 30 min in the dark. Then,
electrophoresis was carried out at 300 mA and 20 V for 20 min, after which slides were carefully
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removed from the chamber and washed three times in neutralization buffer (Tris 0.4 M; pH 7.5) at 4 ◦C.
Cells were stained with SYBR gold fluorophore 10,000× concentrate (Life technologies, USA) diluted
in distilled water for 10 min, and excess stain was washed off with two 5 min distilled water washes.
Comet images were captured at 100× magnification using a Leica I3 filter block and Olympus DP70
camera. Slides were prepared in triplicate, and 50 cells were scored per slide for each experimental
condition. Olive tail moment was calculated for each cell using CometScore analysis software (Tritek
Corp, Sumerduck, VA, USA).
2.7. Modified Long-Run qPCR Technique for DNA-Damage Quantification
Four oligonucleotide primer sets were designed using Primer3 [9] for a long nuclear gene target
of 3129 bp in the E2F transcription factor 1 (E2F1) gene (accession no: AF516106.1; 3427–6565 bp)
and a long mitochondrial target 3723 bp (accession no: NC_012920; 11492–15214 bp). For each
long amplicon target, a matched reverse primer for an internal short amplicon of between 50 and
150 bp was also designed (Table 1). All primer sequences were tested using the primer blast web tool
(http://www.ncbi.nlm.nih.gov/tools/primer-blast/) to ensure primer specificity.
Table 1. Primers designed to amplify large and small products for E2F1 and the mitochondrial targets.
Primer Name Temp. (◦C) Sequence Product Size (bp)
E2F1 large forward 65.2 GAGGCAGGACTCAGGACAAG
3129
E2F1 large reverse 65.2 CTCCTCACATGCAGCTACCA
E2F1 small reverse 65.3 GGATGCCTCAGGGACCAG 164
Mitochondrial large forward 63.6 CGCCTCACACTCATTCTCAA
3723
Mitochondrial large reverse 62.6 AATGTATGGGATGGCGGATA
Mitochondrial small reverse 62.9 CAAGGAAGGGGTAGGCTATG 55
qPCR analysis was performed using a Corbett Rotor-Gene 6000 instrument (Corbett Research,
Mortlake, Australia). All reaction components were optimized through extensive trialing. Final conditions
were: 1× buffer B1, 2.5 mM MgCl2, 1 U Hot FIREPol® DNA Polymerase (Solis Biodyne, Tartu, Estonia),
200 µM dNTPs (Genscript, Piscataway, NJ, USA) and 2 µM SYTO82 fluorophore (Life Technologies,
USA) in a 20 µL reaction volume, which also contained primer at a concentration of 500 nM and
25–50 ng of DNA template (diluted in MQ sterile water). Each reaction was carried out in an Axygen®
optically-clear thin-walled PCR tube (Corning, Tewksbury, MA, USA) in a 36-well rotor. The optimized
cycling conditions (Table 2) included a Hotstart step (10 cycles with a 0.5 ◦C decrease per cycle) and an
extension of 240 s to ensure amplification of the long product.
Table 2. Optimized cycling conditions for quantitative polymerase chain reaction (qPCR).
Cycle Step Incubation Times
Initial denaturation (1 cycle) 95 ◦C at 15 min
Hot start (10 cycles)
Step 1: 95 ◦C at 10 s
Step 2: 65 ◦C (−0.5 ◦C/cycle) at 10 s
Step 3: 72 ◦C at 240 s
Amplification (35 cycles)
Step 1: 95 ◦C at 15 s
Step 2: 60 ◦C at 15 s
Step 3: 72 ◦C at 240 s acquiring to cycling A (yellow channel)
Step 4: 82 ◦C at 10 s acquiring to cycling B (yellow channel)
Melt curve
Ramp from 64 ◦C to 95 ◦C
Hold for 90 s on the 1st step
Hold for 5 s on the subsequent steps. Melt A (yellow channel)
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PCR amplification efficiencies for the target amplicons were calculated by comparative
quantitation using the Corbett Rotor-Gene 6000 Application Software, version 1.7 (Qiagen,Valencia, CA
USA). Average efficiencies for both large and small products across each experimental series were used
for these calculations. Detected lesion rate per 10 kb was determined using the following equation
modified from Lehle et al. [8]:
Lesions per 10 kb = [(ELCpl(Sample) × ES−Cps(Sample)/ELCpl(Control) × ES−Cps(Control))1/a − 1] × 10,000
where EL and ES are the average amplification efficiencies of the large and short product, Cp values are
the crossover (or threshold) values determined by the Rotor-Gene software (Cpl: long; Cps: short), and
a is the number of base pairs of the long fragment. All qPCR reactions for each sample were carried
out in duplicate, and the mean Cp values were used in the calculation of lesions in either genomic or
mitochondrial DNA. An Excel spreadsheet for the above calculation is included in the supplementary
materials (Table S1).
2.8. Data Analysis
Graphs were constructed using Prism v7 (GraphPad Software, La Jolla, CA., USA), with data
expressed as mean ± SE. Results of the qPCR and comet assays were tested using the unpaired t-test
and two-sided p values < 0.05 were considered significant. One-way ANOVA comparison was used to
test differences between means at different time points.
3. Results
3.1. Adherent and Suspension Cancer Cell Lines DNA Damage Quantitation
After 20 or 100 mJ/cm2 UVC (254 nm) was applied to the A549 human lung cancer cell line and
DNA extracted; qPCR was performed on both long and short fragments for both nuclear DNA (nDNA)
and mitochondrial DNA (mtDNA) using our optimized touchdown protocol. Each experiment was
performed in triplicate, and results obtained from two independent investigations. DNA lesion rates
were higher in the mitochondrial than in nuclear DNA templates, with a clear dose response to
UVC exposure in both target amplicons (Figure 1A,B). Due perhaps to variation in Cp values for the
E2F1 fragment between controls, there was no statistically significant nDNA response at 20 mJ/cm2.
A similar pattern of significant DNA damage from both 20 and 100 mJ/cm2 UVC was seen in the THP1
human monocytic leukemia cell line (Figure 1C,D).
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Figure 1. Nuclear DNA (nDNA) and mitochondrial DNA (mtDNA) damage quantitation in cancer
cell lines. Genotoxic stimulation with UVC (20 or 100 mJ/cm2) was assessed in adherent A549 cells in
(A) nDNA and (B) mtDNA, and in the THP1 suspension cell line in (C) nDNA and (D) mtDNA using
qPCR (n = 5). Results are presented as mean ± SE. ** p <0.01, *** p < 0.001, **** p <0.0001.
3.2. DNA Damage Quantitation in PBMCs Using qPCR and the Comet Assay
PBMCs isolated from healthy donor buffy coats were equilibrated overnight in complete media
and then treated with UVC. Aliquots were then taken for either the alkaline comet assay r DNA
extraction for qPCR. Experiments were performed in triplicate from three different PBMC d nors
(n = 9). qPCR revealed a UVC dose response in both nDNA (Figure 2A) a d mtDNA (Figure 2B) across
the nine replicates. Wh the comet assay was able to distinguish betw en control and UVC-exposed
cells (Figure 2C), it failed to discriminat between 20 and 100 mJ/cm2 d s s, with significant variation
in Olive tail moment observed (Figure 2D). The authors who first reported the LORD-Q approach
also demonstrated the superiority of qPCR over the alkaline comet assay in detecting low-level DNA
damage induced by exposure to bleomycin in Jurkat T cells [8].
3.3. Effect of Cryopreservation on DNA Damage Quantitation in PBMC’s
The use of the qPCR assay in quantifying UVC-induced DNA damage in cryopreserved PBMCs
was assessed (Figure 3). Experiments were performed in triplicate from one PBMC donor (n = 3).
For the nuclear DNA target (E2F1), the mean lesion rates observed across five time points from t = 0
(fresh) to t = 12 weeks at −80 ◦C after treatment with 20 mJ of UVC were not significantly different
(p = 0.36). In contrast, induced DNA damage in the mitochondrial fragment was significantly greater
at t = 0 (mean 7.3 lesions/10 kb) than at subsequent time points (p = 0.034). We observed that no
further deterioration in DNA integrity was found over a 12 week period in either mitochondrial or
nuclear DNA, with cells stored for different periods of time giving similar DNA damage response to
UVC challenge.
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reduce analysis time and offer a significant level of sensitivity and reproducibility. They also improve 
on the comet assay with sequence-specific DNA damage, quantifying the effects of potential toxicants 
separately on nuclear and mitochondrial DNA. 
Initially, we evaluated the LORD-Q method using primer sets as previously described [8], 
testing for amplification of both the large nuclear gene (p53) (3075 bp) and large mitochondrial  
(3723 bp) products. qPCR was carried out using the recommended KAPAG2 (Peqlab) enzyme and 
cycling conditions with the SYTO82 fluorophore using a Corbett Rotor-Gene 6000 (Qiagen). We also 
tried substituting the enzyme for the FIREPol®  DNA Polymerase (Solis BioDyne), but the 
amplification gave variable results with a number of non-specific products. This was particularly 
evident for the p53 product, as confirmed by gel electrophoresis. Through a series of investigations, 
we eventually optimized this assay by targeting different DNA regions, using a less expensive 
HotFirePOL enzyme/SYTO82 fluorophore combination (approximately six times cheaper than the 
LORD-Q approach) and establishing the best cycling conditions for use on our own qPCR system. 
We chose E2F1 as a nuclear DNA target, as this gene plays a key role in cell cycle regulation, is likely 
to be in a transcriptionally-active region of the genome, and is therefore susceptible to 
experimentally-induced damage [10]. We anticipate that there would be a multitude of suitable 
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instruments. The reproducibility of this modified qPCR assay was validated using UVC treatment
(254 nm) initially in adherent (A549) and suspension (THP1) cancer cells lines, then in PBMCs due to a
forthcoming clinical investigation involving such samples. Moreover, the comparison between levels
of induced DNA damage in cryopreserved versus freshly-isolated PBMCs informs future experimental
methodologies and clinical trial material handling protocols.
Initial assay validation using UVC to damage THP1 and A549 cell lines demonstrated reproducible
damage quantification in both nDNA and mtDNA, which was very close to what had initially been
shown in Jurkat T-cells in the LORD-Q study [8]. Alternative approaches to measuring DNA damage in
THP1 cells have shown similar UVC-induced damage. In addition to inducing hydrolytic and oxidative
damage, UVC induces bipyrimidine sites in cellular DNA to form cyclobutane pyrimidine dimers, (6–4)
photoproducts and their Dewar isomers [11]. Using high performance liquid chromatography with
electrospray ionization tandem mass spectroscopy (HPLC-MS/MS), the UVC-induced bipyrimidine
lesion rate in THP1 cells was approximately 1 lesion per 1 × 104 base pairs per 10 mJ/cm2 at a cell
concentration of 6 × 106/cm2 [12]. Interestingly, A549 and THP1 cells had much higher damage in
mtDNA than nDNA, which was similar to another study, where Jurkat T cells had been damaged by
UVC [8]. Mitochondrial DNA has been shown to be more sensitive to oxidative stress than nDNA [13],
perhaps related to its proximity to a major source of endogenous reactive oxygen species, namely the
electron transport chain located in the inner mitochondrial membrane. Furthermore, the nucleotide
excision repair pathway responsible for repairing helix-distorting lesions (such as UVC-induced
photoproducts) is absent in mitochondria [14].
While the comet assay is still regarded as the standard genotoxicity assay, it does have a number of
limitations. Firstly, standardization of assay conditions is vital in reducing intra-assay variability [15];
even small changes in agarose concentration, alkaline unwinding times, and electrophoresis conditions
can significantly alter the results. Additionally, even with the use of comet scoring software, bias can be
introduced into the scoring process and, although the comet can be scaled up to deal with large sample
numbers, significant time resources are required to perform the assay, then capture and score the
images. In comparison, a qPCR-based technique provides a relative rather than absolute measurement
of DNA damage. It allows differences in mitochondrial and nuclear damage to be compared, and can
provide gene/region-specific information that may clarify our understanding of certain pathological
processes. To our knowledge, this report is the first comparison of a qPCR-based DNA damage assay
with the comet assay in PBMCs. The results show our optimized protocol to be a suitable alternative
technique to the comet assay in quantifying genotoxicity from UVC exposure in PBMCs in a time and
reagent cost-efficient manner.
The use of human lymphocyte-based model systems for screening chemical compounds for
cytotoxicity or cytoprotection is well-established. The cryopreservation of lymphocytes enables
long-term storage and allows down-stream assays (such as toxicity assays) on cells collected over an
extended period of time, such as in a clinical study. The study of DNA damage and repair has been
performed in cryopreserved PBMCs using the comet assay [16]. Whilst the isolation of PMBCs from
whole blood is associated with some DNA damage, the additional cryopreservation step should not
contribute to further damage, with responses following the induction of oxidative stress being similar
between frozen and fresh lymphocytes [17]. Indeed, we observed that no further deterioration in DNA
integrity was found in either mitochondrial or nuclear DNA over a 12 week period, with cells stored
for different periods of time giving similar DNA damage response to UVC challenge. The utility of this
approach has been demonstrated here in both fresh and in cryopreserved PBMCs, and can be applied
to the analysis of tissue-banked samples in a high throughput qPCR format.
Finally, assay validation using the cytotoxic chemotherapy agents bleomycin and cisplatin in
revived PBMCs revealed variable susceptibility to their genotoxic effects. The observed lower levels
of damage in nDNA in unstimulated PBMCs is not unexpected, given that previous studies on
DNA damage following a 30 min exposure of phytohemagglutinin-stimulated PBMCs to bleomycin
20 µg/mL have shown a very low level of damage, as assessed by the alkaline comet assay,
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with <1% DNA in the tail [18]. A semi-quantitative PCR approach also showed nDNA from
SV40-transformed human fibroblasts to be more sensitive than mtDNA to damage following incubation
with cisplatin [19]. Other PCR-based studies have been undertaken using cisplatin, where DNA
adducts were measured in a p53 nuclear DNA target in donor PBMC cell lysates [20], and a lesion
frequency of ~1.2/104 nucleotides was estimated after a 3 h treatment with 100 µg/mL cisplatin.
However, this is not directly comparable to our data, where cisplatin was used at lower concentrations
for 24 h incubations and PCR was performed on high quality extracted DNA rather than directly on
cell lysates.
5. Conclusions
The successful assay implementation of a qPCR assay to measure nDNA and mtDNA damage
requires optimization of primers from selected targets and qPCR cycling conditions for a given PCR
platform and experimental system/cell line. Our comparison of induced DNA damage in fresh and
cryopreserved PBMCs provides the basis for future applications, such as human bio-monitoring
studies of bio-banked samples. This assay is recommended as a useful and versatile tool to assess
DNA damage within genomic and mitochondrial DNA in any eukaryotic system, even in the same
PCR run across different experimental groups.
Supplementary Materials: The following are available online at www.mdpi.com/2079-7737/5/4/39/s1, Table S1:
qPCR DNA damage calculator.
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